---
schema_version: "secwatch.filing_event.v1"
accession: "0001121702-24-000012"
form_type: "8-K"
ticker: null
cik: "0001121702"
company_name: "YIELD10 BIOSCIENCE, INC."
filed_at: "2024-02-16T23:59:59+00:00"
generated_at: "2026-06-06T00:02:39.659688+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.82
calibrated_materiality_score: 0.82
confidence: "high"
source: SEC EDGAR
---

# Yield10 Bioscience granted Nasdaq extension until May 13, 2024, subject to conditions

## Summary
- Panel granted extension to May 13, 2024, after Feb 6 hearing; conditions include a written financing update by Mar 15.
- Company remains non-compliant with minimum stockholders' equity and $1.00 bid price requirements on Nasdaq.
- Bid price compliance period ends Mar 25, 2024; may seek additional 180-day period if not met.
- No assurance that Yield10 can satisfy ongoing listing criteria during the extension period.

## SEC filing metadata
- accession: 0001121702-24-000012
- form_type: 8-K
- cik: 0001121702
- company_name: YIELD10 BIOSCIENCE, INC.
- filed_at: 2024-02-16T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.82
- calibrated_materiality_score: 0.82
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000012/0001121702-24-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000012/yten-20240213.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001121702-24-000012
- JSON: https://secwatch.observer/filing/0001121702-24-000012.json
- Plain text: https://secwatch.observer/filing/0001121702-24-000012.txt

## Key facts
- Listing & Compliance Notices
  YIELD10 BIOSCIENCE, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: September 25, 2023, Yield10 received a deficiency letter from the Staff notifying the Company that it was not in compliance with the requirement to maintain a minimum bid price of at least $1.00 per share pursuant to Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until March 25, 2024, to regain compliance with this listing requirement. To regain compliance, the closing bid price of the Company’s common stock must be $1.00 per share or more for a minimum of 10 consecutive business day
  evidence_url: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000012/0001121702-24-000012-index.htm
- Listing & Compliance Notices
  YIELD10 BIOSCIENCE, INC. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: extension granted
  - Deficiency: stockholders equity
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: nce with Nasdaq requirements. Also as previously disclosed, on September 25, 2023, Yield10 received a deficiency letter from the Staff notifying the Company that it was not in compliance with the requirement to maintain a minimum bid price of at least $1.00 per share pursuant to Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until March 25, 2024, to regain compliance with this listing requirement. To regain compliance, the closing bid price of the Company’s common stock must be $1.00
  evidence_url: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000012/0001121702-24-000012-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.